These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24931286)

  • 1. Necrosis targeted combinational theragnostic approach using radioiodinated Sennidin A in rodent tumor models.
    Ji Y; Jiang C; Zhang X; Liu W; Gao M; Li Y; Wang J; Wang Q; Sun Z; Jiang X; Yao N; Wang X; Fang Z; Yin Z; Ni Y; Zhang J
    Oncotarget; 2014 May; 5(10):2934-46. PubMed ID: 24931286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis targeted radiotherapy of non-small cell lung cancer using radioiodinated protohypericin in a mouse model.
    Liu X; Jiang C; Zhang D; Gao M; Peng F; Huang D; Sun Z; Ni Y; Zhang J; Yin Z
    Oncotarget; 2015 Sep; 6(28):26400-10. PubMed ID: 26305548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring diagnostic potentials of radioiodinated sennidin A in rat model of reperfused myocardial infarction.
    Jiang C; Gao M; Li Y; Huang D; Yao N; Ji Y; Liu X; Zhang D; Wang X; Yin Z; Jing S; Ni Y; Zhang J
    Int J Pharm; 2015 Nov; 495(1):31-40. PubMed ID: 26302863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential systemic administrations of combretastatin A4 Phosphate and radioiodinated hypericin exert synergistic targeted theranostic effects with prolonged survival on SCID mice carrying bifocal tumor xenografts.
    Li J; Cona MM; Chen F; Feng Y; Zhou L; Zhang G; Nuyts J; de Witte P; Zhang J; Yu J; Oyen R; Verbruggen A; Ni Y
    Theranostics; 2013; 3(2):127-37. PubMed ID: 23423247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing intratumoral biodistribution and antitumor activity of nab-paclitaxel through combination with a vascular disrupting agent, combretastatin A-4-phosphate.
    Gao M; Zhang D; Yao N; Jin Q; Jiang C; Zhang J; Wang F
    Cancer Chemother Pharmacol; 2019 Dec; 84(6):1187-1194. PubMed ID: 31520101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First Evaluation of Radioiodinated Flavonoids as Necrosis-Avid Agents and Application in Early Assessment of Tumor Necrosis.
    Liang J; Sun Z; Zhang D; Jin Q; Cai L; Ma L; Liu W; Ni Y; Zhang J; Yin Z
    Mol Pharm; 2018 Jan; 15(1):207-215. PubMed ID: 29226682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical Evaluation of Radioiodinated Hoechst 33258 for Early Prediction of Tumor Response to Treatment of Vascular-Disrupting Agents.
    Zhang D; Gao M; Yao N; Jiang C; Liu W; Li T; Song S; Huang D; Yin Z; Qiu Y; Jin Q
    Contrast Media Mol Imaging; 2018; 2018():5237950. PubMed ID: 29681781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A poly(l-glutamic acid)-combretastatin A4 conjugate for solid tumor therapy: Markedly improved therapeutic efficiency through its low tissue penetration in solid tumor.
    Liu T; Zhang D; Song W; Tang Z; Zhu J; Ma Z; Wang X; Chen X; Tong T
    Acta Biomater; 2017 Apr; 53():179-189. PubMed ID: 28167300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Glycosylation on Biodistribution and Imaging Quality of Necrotic Myocardium of Iodine-131-Labeled Sennidins.
    Li L; Zhang D; Yang S; Song S; Li J; Wang Q; Wang C; Feng Y; Ni Y; Zhang J; Liu W; Yin Z
    Mol Imaging Biol; 2016 Dec; 18(6):877-886. PubMed ID: 27172937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combretastatin-A4 phosphate improves the distribution and antitumor efficacy of albumin-bound paclitaxel in W256 breast carcinoma model.
    Gao M; Zhang D; Jin Q; Jiang C; Wang C; Li J; Peng F; Huang D; Zhang J; Song S
    Oncotarget; 2016 Sep; 7(36):58133-58141. PubMed ID: 27531898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two vascular-disrupting agents at a clinically relevant dose in rodent liver tumors with multiparametric magnetic resonance imaging biomarkers.
    Wang H; Cona MM; Chen F; Yu J; Feng Y; Li J; Keyzer FD; Marchal G; Ni Y
    Anticancer Drugs; 2012 Jan; 23(1):12-21. PubMed ID: 21857503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The first study on therapeutic efficacies of a vascular disrupting agent CA4P among primary hepatocellular carcinomas with a full spectrum of differentiation and vascularity: Correlation of MRI-microangiography-histopathology in rats.
    Liu Y; De Keyzer F; Wang Y; Wang F; Feng Y; Chen F; Yu J; Liu J; Song S; Swinnen J; Bormans G; Oyen R; Huang G; Ni Y
    Int J Cancer; 2018 Oct; 143(7):1817-1828. PubMed ID: 29707770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved therapeutic outcomes of thermal ablation on rat orthotopic liver allograft sarcoma models by radioiodinated hypericin induced necrosis targeted radiotherapy.
    Gao L; Zhang J; Ma T; Yao N; Gao M; Shan X; Ni Y; Shao H; Xu K
    Oncotarget; 2016 Aug; 7(32):51450-51461. PubMed ID: 27285983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and Evaluation of Ga-68-Labeled Rhein for Early Assessment of Treatment-Induced Tumor Necrosis.
    Zhang A; Wu T; Bian L; Li P; Liu Q; Zhang D; Jin Q; Zhang J; Huang G; Song S
    Mol Imaging Biol; 2020 Jun; 22(3):515-525. PubMed ID: 31250330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-individual comparison of therapeutic responses to vascular disrupting agent CA4P between rodent primary and secondary liver cancers.
    Liu YW; De Keyzer F; Feng YB; Chen F; Song SL; Swinnen J; Bormans G; Oyen R; Huang G; Ni YC
    World J Gastroenterol; 2018 Jul; 24(25):2710-2721. PubMed ID: 29991876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and Evaluation of Rhein-Based MRI Contrast Agents for Visualization of Tumor Necrosis Induced by Combretastatin A-4 Disodium Phosphate.
    Zhang L; Zhang D; Gao M; Jin Q; Jiang C; Wu T; Feng Y; Ni Y; Yin Z; Zhang J
    Mol Imaging Biol; 2021 Apr; 23(2):220-229. PubMed ID: 33048270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dual-targeting anticancer approach: soil and seed principle.
    Li J; Sun Z; Zhang J; Shao H; Cona MM; Wang H; Marysael T; Chen F; Prinsen K; Zhou L; Huang D; Nuyts J; Yu J; Meng B; Bormans G; Fang Z; de Witte P; Li Y; Verbruggen A; Wang X; Mortelmans L; Xu K; Marchal G; Ni Y
    Radiology; 2011 Sep; 260(3):799-807. PubMed ID: 21712473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPECT Imaging of Treatment-Related Tumor Necrosis Using Technetium-99m-Labeled Rhein.
    Liang J; Luo Q; Zhang D; Jin Q; Liu L; Liu W; Gao M; Zhang J; Yin Z
    Mol Imaging Biol; 2019 Aug; 21(4):660-668. PubMed ID: 30338432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of rodent liver tumor with combretastatin a4 phosphate: noninvasive therapeutic evaluation using multiparametric magnetic resonance imaging in correlation with microangiography and histology.
    Wang H; Sun X; Chen F; De Keyzer F; Yu J; Landuyt W; Vandecaveye V; Peeters R; Bosmans H; Hermans R; Marchal G; Ni Y
    Invest Radiol; 2009 Jan; 44(1):44-53. PubMed ID: 19034028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Necrosis targeted radiotherapy with iodine-131-labeled hypericin to improve anticancer efficacy of vascular disrupting treatment in rabbit VX2 tumor models.
    Shao H; Zhang J; Sun Z; Chen F; Dai X; Li Y; Ni Y; Xu K
    Oncotarget; 2015 Jun; 6(16):14247-59. PubMed ID: 26036625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.